OHE is delighted to welcome Prof David Parkin as a visiting researcher at OHE over the coming months. A long-standing member of the EuroQol Group, Prof Parkin's expertise will provide valuable insights for OHE's current research programme around EQ-5D topics.
OHE’s Prof Nancy Devlin presented at two key workshops held for researchers and HTA policy makers from across Asia. The workshops were organised by Prof Nan Luo, National University of Singapore, in collaboration with the EuroQol Group.
19 March: Jon Sussex will be at BioWales 2013 speaking on the health and wider economic benefits of life sciences research. 21 March: Jorge Mestre-Ferrandiz will give his updated annual presentation on the economics of the market for medicines at City College in London. 21/22 March: Nancy Devlin will be in Singapore with EuroQol colleagues. Until 12 April, OHE is accepting applications for a fixed-term position for an economist. Keep up with the latest!
At a recent meeting of the Pharmaceutical Onology Initiative’s (POI) HTA group, OHE’s Nancy Devlin provided an overview of the EuroQol Group’s scientific research agenda for the coming year and plans for the EQ-5D-5L approach to measuring patient-reported outcomes of care.
In a paper presented at the January 2013 Health Economics Study Group meeting, David Parkin of the NHS and OHE’s Nancy Devlin and Yan Feng examined what may cause the two-cluster shape of EQ-5D indexes. This is important because these indexes are used widely in other analyses that affect health care resource decisions.
OHE’s Prof Nancy Devlin and Prof Ben van Hout of the University of Sheffield have been awarded a £457,000 grant from the Policy Research Programme (PRP) of the UK’s National Institute for Health Research (NIHR) for research to produce an EQ-5D-5L Value Set for England.
OHE team members have been active in a number of external seminars, conferences and workshops. These included gatherings of academic experts, discussions involving governments, and meetings organised by the pharmaceutical industry.
The NHS Patient Reported Outcome Measures (PROMs) programme, introduced in April 2009, is a significant development in the routine collection and use of patient reported outcome data. Currently, data are collected from patients both before and after surgery for four elective surgical procedures in the NHS, with plans to expand the practice.